Documente Academic
Documente Profesional
Documente Cultură
BUTYLROPHENONE:
MOA: blockade of D2 receptors more than 5-HT2a receptors DRUGS:
FOR: schizophrenia, bipolar disorder, Huntington’s chorea, >HALOPERIDOL – some a-receptor block, minimal M-receptor
Tourette’s syndrome block, less sedation than phenothiazine
TXY: Extrapyramidal dysfunction
ATYPICAL ANTIPSYCHOTICS
MOA: blockade of 5-HT2 receptors more than D2 DRUGS:
FOR: Schizophrenia (improve positive & negative symptoms), >ARIPIPRAZOLE – major depression
bipolar disorder, agitation in Alzheimer’s & Parkinson’s >CLOZAPINE - some a-block, M-receptor block
>OLANZAPINE - M-receptor block, Bipolar w/ lithium
TXY: Agranulocytosis (clozapine), Hyperprolactinemia >QUETIAPINE-
(risperidone), QT prolongation (ziprasidone), diabetes, >RISPERIDONE – some a-block, Bipolar w/ lithium
hypercholesterolemia, wt gain (clozapine, olanzapine). >ZIPRASIDONE - some a-block
COMMON: variable H1-receptor block
LITIUM
MOA: uncertain, suppresses inositol signaling, inhibits GSK-3
FOR: Bipolar disorder -prophylactic use can prevent mood swings between mania & depression
TXY: Tremor, edema, hypothyroidism, renal dysfunction, dysrhythmias, pregnancy c: D, clearance ↓ by thiazides and nsaids
EFFECTS: No antagonizing actions on autonomic nervous system receptors/ CNS receptors • no sedative effects
DRUGS:
>CARBAMAZEPINE –acute mania, prophylaxis in depressive phase
cause: diplopia, ataxia
TXY: Hematotoxicity and induction of P450 drug metabolism